Skip to main content
Log in

Synthesis of Mono-PEGylated Growth Hormone Releasing Peptide-2 and Investigation of its Biological Activity

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The purpose of this study was to investigate an efficient synthetic route to the mono-PEGylated growth hormone releasing peptide-2 (GHRP-2) and its biological activity in vivo. The commercially available key PEGylating reagent, mPEG-NHS ester, was successfully utilized to the synthesis of mono-PEGylated GHRP-2, during which the PEGylation profiles of GHRP-2 were monitored by high-performance liquid chromatography (HPLC). The product was purified by cation exchange chromatography, and its biological activity was conducted in rats. The desired mono-PEGylated GHRP-2 as the major product was readily obtained in anhydrous aprotic solvent, such as dimethyl formamide (DMF) and dimethylsulfoxide (DMSO), when the molar ratio of mPEG-NHS ester to GHRP-2 was fixed to be 0.8:1. The products were characterized by matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry. The evaluation of the biological activity for the products showed that the mono-PEGylated GHRP-2 gave a more stable activity than GHRP-2, suggesting that PEGylation led to the increase in the half-life of GHRP-2 in plasma without greatly impairing the biological activity. PEGylation of the GHRP-2 is a good choice for the development of the GHRP-2 applications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

REFERENCES

  1. Bowers CY. GH releasing peptides: structure and kinetics. J Pediatr Endocrinol. 1993;6:21–31.

    Article  CAS  PubMed  Google Scholar 

  2. Bowers CY, Sartor AO, Reynolds GA, Badger TM. On the actions of the growth hormone-releasing hexapeptide. GHRP Endocrinol. 1991;128:2027–35.

    Article  CAS  Google Scholar 

  3. Sawada H. Effect of newly developed analogue of growth hormone releasing peptide [D-Ala-D-beta Nal-Ala-Trp-D-Phe-Lys-NH2 (KP-102)] on growth hormone secretion in adult male rats. Nihon Ika Daigaku Zasshi. 1995;62(2):142–9.

    Article  CAS  PubMed  Google Scholar 

  4. Furuta S, Shimada O, Doi N, Ukai K, Nakagawa T, Watanabe J, et al. General pharmacology of KP-102 (GHRP-2), a potent growth hormone-releasing peptide. Arzneimittelforschung. 2004;54(12):868–80.

    CAS  PubMed  Google Scholar 

  5. Pihoker C, Middleton R, Reynolds GA, Bowers CY, Badger TM. Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature. Clin Endocrinol Metab. 1995;80(10):2987–92.

    CAS  Google Scholar 

  6. Peroni CN, Hayashida CY, Nascimento N, Longuini VC, Toledo RA, Bartolini P, et al. Growth hormone response to growth hormone-releasing peptide-2 in growth hormone-deficient little mice. Clinics (Sao Paulo). 2012;67(3):265–72.

    Article  Google Scholar 

  7. Greenwald RB, Choe YH, Mcguire J, Conover CD. Effective drug delivery by PEGylated drug conjugates. Adv Drug Deliv Rev. 2003;55(2):217–50.

    Article  CAS  PubMed  Google Scholar 

  8. Veronese FM, Pasut G. PEGylation, successful approach to drug delivery. Drug Discov Today. 2005;10:1451–8.

    Article  CAS  PubMed  Google Scholar 

  9. Matsushima A, Kodera Y, Hiroto M, Nishimura H, Inada Y. Bioconjugates of proteins and polyethylene glycol: potent tools in biotechnological processes. J Mol Catal B Enzym. 1996;2:1–17.

    Article  CAS  Google Scholar 

  10. Pepinsky RB, Lepage DJ, Gill A, Chakraborty A, Vaidyanathan S, Green M, et al. Improved pharmacokinetic properties of a polyethylene glycol-modified form of interferon-b-1a with preserved in vitro bioactivity. J Pharmacol Exp Ther. 2001;297(3):1059–66.

    CAS  PubMed  Google Scholar 

  11. Hooftman G, Herman S, SSchacht E. Poly(ethylene glycols)s with reactive endgroups. II. Practical consideration for the preparation of protein-PEG conjugates. J Bioact Compat Polym. 1996;11:135–59.

    CAS  Google Scholar 

  12. Lee LS, Conover CD, Shi C. Prolonged circulating lives of single-chain Fv proteins conjugated with polyethylene glycol: a comparison of conjugation chemistries of conjugation chemistries and compounds. Bioconjugate Chem. 1999;10:973–81.

    Article  CAS  Google Scholar 

  13. Grace MJ, Lee S, Bradshaw S. Site of pegylation and polyethylene glycol molecule size attenuate interferon-alpha antiviral and antiproliferative activities through the JAK/STAT signaling pathway. J Biol Chem. 2005;280(8):6327–36.

    Article  CAS  PubMed  Google Scholar 

  14. Esposito P, Barbero L, Caccia P. PEGylation of growth hormone-releasing hormone (GRF) analogues. Adv Drug Deliv Rev. 2003;55:1279–91.

    Article  CAS  PubMed  Google Scholar 

  15. Nojima Y, Iguchi K, Suzuki Y, Sato A. The pH-dependent formation of PEGylated bovine lactoferrin by branched polyethylene glycol (PEG)-N-hydroxysuccinimide (NHS) active esters. Biol Pharm Bull. 2009;32(3):523–6.

    Article  CAS  PubMed  Google Scholar 

  16. Eun JP, Tae HT, Dong HN, Kang CL. Effect of PEGylation on stability of peptide in poly(lactide-co-glycolide) microspheres. Arch Pharm Res. 2010;33(7):1111–6.

    Article  Google Scholar 

  17. Meng ZP, CAO ZP, Wang WS. Synthesizing process of polyethylene glycol mono methyl ether. CN 100586984 C. 2010-2-3.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Beihua Xu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hu, X., Xu, B. & Zhou, Z. Synthesis of Mono-PEGylated Growth Hormone Releasing Peptide-2 and Investigation of its Biological Activity. AAPS PharmSciTech 16, 1213–1219 (2015). https://doi.org/10.1208/s12249-015-0307-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-015-0307-z

KEY WORDS

Navigation